- Home
- HYPR vs KRON Comparison
HYPR vs KRON Comparison
Compare HYPR & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYPR
- KRON
- Stock Information
- Founded
- HYPR 2014
- KRON 2017
- Country
- HYPR United States
- KRON United States
- Employees
- HYPR N/A
- KRON 8
- Industry
- HYPR Medical Specialities
- KRON Medicinal Chemicals and Botanical Products
- Sector
- HYPR Health Care
- KRON Health Care
- Exchange
- HYPR Nasdaq
- KRON Nasdaq
- Market Cap
- HYPR 54.0M
- KRON 54.1M
- IPO Year
- HYPR N/A
- KRON 2020
- Fundamental
- Price
- HYPR $0.75
- KRON $0.88
- Analyst Decision
- HYPR Strong Buy
- KRON Buy
- Analyst Count
- HYPR 3
- KRON 3
- Target Price
- HYPR $1.06
- KRON $1.63
- AVG Volume (30 Days)
- HYPR 6.1M
- KRON 1.4M
- Earning Date
- HYPR 08-07-2025
- KRON 08-07-2025
- Dividend Yield
- HYPR N/A
- KRON N/A
- EPS Growth
- HYPR N/A
- KRON N/A
- EPS
- HYPR N/A
- KRON N/A
- Revenue
- HYPR $11,732,000.00
- KRON $9,192,000.00
- Revenue This Year
- HYPR $12.31
- KRON N/A
- Revenue Next Year
- HYPR $29.29
- KRON N/A
- P/E Ratio
- HYPR N/A
- KRON N/A
- Revenue Growth
- HYPR 0.34
- KRON 21.16
- 52 Week Low
- HYPR $0.53
- KRON $0.65
- 52 Week High
- HYPR $1.90
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- HYPR 51.70
- KRON 65.76
- Support Level
- HYPR $0.66
- KRON $0.87
- Resistance Level
- HYPR $0.74
- KRON $0.90
- Average True Range (ATR)
- HYPR 0.06
- KRON 0.02
- MACD
- HYPR -0.00
- KRON 0.00
- Stochastic Oscillator
- HYPR 32.51
- KRON 53.86
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.